Dennis O'Donnell Email & Phone Number

Millis, MA, US

Princeton, NJ

Mr. O’Donnell has been an Operating Partner at Dana Healthcare Holdings (“Dana”) since 2010. Dana is an independent sponsor private equity firm focused on lower middle market consumer healthcare companies. In addition to assisting in M&A due diligence, he provides Marketing, New Product Development and Regulatory support to Dana current or former portfolio.

Somerville, NJ

Core Consumer Healthcare is the maker of PreVencia Nasal Spray Cold & Flu Blocker, a patent-pending formulation that combines a clinically-proven ionic nasal technology which traps cold and flu viruses in the nasal canal with two natural antiviral ingredients that kill the viruses on contact.

New Hope, PA

As Senior Business Advisor, Mr. O'Donnell is providing Marketing, New Product Development and Regulatory support to Huggibles Pet Nutrition, a current Dana Healthcare Holdings portfolio company.

Princeton, NJ

He served as an Operating Executive at KB Financial Advisory Partners (“KB”) from 2016 until 2023. At KB, he provided M&A, strategic and regulatory advisory services to lower middle market consumer healthcare and healthcare services companies.

United States

Executive Forum is a highly engaged community of executives from leading corporations who share a pasion for "what's next" to drive the business growth of tomorrow. SInce its formation in 1995, the Executive Forum has grown to over 400 members who are the top-most leaders at market moving companies, run portfolios for the most innovative PE firms and serve.

Bridgewater, NJ

He led the integration team at Arcadia for the acquisition of the Nizoral Shampoo business. Arcadia was funded by Avista Capital Partners and Dana Holdings LLC in early 2018 to acquire Kramer Laboratories and Nizoral Shampoo assets in North America from J&J.

New York, NY

From 2016 to 2018, Mr. O'Donnell served as CEO of Izun Oral Care, which marketed two clinically proven treatments sold directly to dentists to address periodontal disease. Straumann AG acquired the global rights to Izun's product line in June 2018.

Somerville, NJ

Mr. O'Donnell was co-founder and CEO of Ducere Pharma, which was owned by Dana Holdings and Casla Partners. Ducere acquired six well-known OTC brands from Novartis (including Bufferin, Doan’s, Comtrex, Nupercainal, Myoflex and Cruex) and later sold to Dr. Reddy's Labs in May 2016.

Somerville, NJ

In October 2011, he was co-founder and CEO of Parilis Biopharma, where he raised $3 million to license rights to a Humira biosimilar molecule from Oncobiologics.

Scottsdale, AZ

In 2010, he co-founded Primus Therapeutics as an acquisition vehicle to purchase the Matrixx Initiatives business (the makers of Zicam cold remedies) with HIG Capital and Dana Holdings in February 2011. He ran the company as interim CEO and restored the business to profitability. Matrixx was sold in December 2017 to Gryphon Investors.

Chicago, IL

NextWave, together with its development partner Tris Pharma, developed patented sustained release products for the pediatric population via an accelerated regulatory pathway (505b2). Two of its products gained FDA approval. The company was later sold to Pfizer for $680 million in milestone payments.

Jenkintown, PA

Developed the company's strategy to pursue accelerated FDA approval of Dynamis' proprietary dermatology products. It also developed and marketed a line of advanced skin care products to dermatologists and plastic surgeons.

New York, NY

Restored the parent company to profitability. Was also CEO of BioBalance Corp., the company's wholly-owned biopharmaceutical subsidiary which gained FDA approval for a phase II clinical trial of ProBactrix for pouchitis, an orphan drug GI indication.

New York, NY; Richmond, VA And Madison, NJ

Ran several key OTC businesses including Respiratory, GI and Topical business units, Senior VIce President of Global Business Development and president of Solgar, the leading nutraceutical brand in the health food channel.

Mba, Finance & Marketing

Bs Pharmacy, Pharmacy, Dean'S List